BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perrone S, Passucci M, Ortu La Barbera E, Capriata M, Ferretti A, Mecozzi A, Giovangrossi P, Equitani F, Cimino G. Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura. J Clin Apher 2021;36:499-504. [PMID: 33459440 DOI: 10.1002/jca.21877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gómez-Seguí I, Pascual Izquierdo C, de la Rubia Comos J. Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura. Expert Rev Hematol 2021;14:707-19. [PMID: 34275393 DOI: 10.1080/17474086.2021.1956898] [Reference Citation Analysis]